Skip to Content
Breast Tumor Proteomics

Computational Omics Funding Opportunity

Up to $2 million dollars is available for projects that use publicly available computational omics to better understand cancer.

For more information, click here.

Clinical Proteomic Tumor Analysis Consortium

The National Cancer Institute (NCI), part of the National Institutes of Health, announced the launch of a Clinical Proteomic Tumor Analysis Consortium (CPTAC) in August 2011. CPTAC is a comprehensive and coordinated effort to accelerate the understanding of the molecular basis of cancer through the application of robust, quantitative, proteomic technologies and workflows. Read more.  


  • Zhang B, Wang J, Wang X, Zhu J, et al. (2014) Proteogenomic characterization of human colon and rectal cancer Nature . Epub ahead of Print View PubMed Abstract.
  • Whiteaker JR, Halusa GN, Hoofnagle AN, Sharma V, MacLean B, Yan P, et al (2014) CPTAC Assay Portal: a repository of targeted proteomic assays. Nat Methods. 11 (7): 703-4. View PubMed Abstract.
  • Carr SA, Abbatiello SE, Ackermann BL, Borchers C, Domon B, Deutsch EW, Grant RP, Hoofnagle AN, Hüttenhain R, et al. (2014) Targeted Peptide Measurements in Biology and Medicine: Best Practices for Mass Spectrometry-based Assay Development Using a Fit-for-Purpose Approach. Mol Cell Proteomics 13 (3): 907-17. Epub 2014 Jan 17 View PubMed Abstract..

View All »